Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
Neurobiology of Disease|January 11, 2014
A novel GABRG2 mutation, p.R136*, in a family with GEFS+ and extended phenotypesAnn J Johnston, Jing-Qiong Kang, Wangzhen Shen, et al.
Epilepsia|July 11, 2024
Incomplete resection of the intracranial electroencephalographic seizure onset zone is not associated with postsurgical outcomesSarah J Gascoigne, Nathan Evans, Gerard Hall, et al.
Therapeutic Advances in Neurological Disorders|May 25, 2026
Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countriesCarmen de Keijzer, Jian-Yu E, Qian Yang, et al.
Scientific Reports|October 18, 2016
Targeted suppression of autoreactive CD8<sup>+</sup> T-cell activation using blocking anti-CD8 antibodiesMathew Clement, James A Pearson, Stephanie Gras, et al.
Brain Communications|June 26, 2023
Variation in prognosis and treatment outcome in juvenile myoclonic epilepsy: a Biology of Juvenile Myoclonic Epilepsy Consortium proposal for a practical definition and stratified medicine classificationsGuido Rubboli, Christoph P Beier, Kaja K Selmer, et al.
Clinical Medicine (London, England)|April 20, 2024
Addressing ethnic disparities in neurological research in the United Kingdom: An example from the prospective multicentre COVID-19 Clinical Neuroscience StudyDaniel J van Wamelen, Silvia Rota, Monika Hartmann, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 16, 2010
Pathophysiological mechanisms of dominant and recessive GLRA1 mutations in hyperekplexiaSeo-Kyung Chung, Jean-François Vanbellinghen, Jonathan G L Mullins, et al.
Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.
Seizure|January 22, 2025
Top Ten epilepsy research priorities: A UK priority setting partnershipAnna C Norton, Caoimhe Twohig-Bennett, Maxine Smeaton, et al.
JAMA Network Open|January 10, 2022
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United KingdomChanjira Satukijchai, Romina Mariano, Silvia Messina, et al.
Pageof 18